Open-label Study to Evaluate Safety of Multiple Courses of IM Alefacept During Treatment of Chronic Plaque Psoriasis

NCT00692172 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

175

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis

Interventions

DRUG: Alefacept

Sponsor

Astellas Pharma Inc

Collaborators

[object Object]